Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROfind: 68Ga-PSMA-R2 in Prostate Cancer
NCT03490032Phase 2Completed
- Sponsor
- Advanced Accelerator Applications
- Start
- May 2018
- Primary completion
- Aug 2019
- Modality
- Radiopharmaceutical, CA (Contrast Agent)
- Countries
- 1
01
Overview
A Phase 2 trial of gallium-68 PSMA-R2 in prostate cancer (PCa), sponsored by Advanced Accelerator Applications. Started May 2018; status: completed.
02
Drugs
gallium-68 PSMA-R2
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03490032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03490032.